Trades on 2 secondary markets

Pretzel Therapeutics

Pretzel Therapeutics is a biopharmaceutical company developing first-in-class medicines that target mitochondrial biology and cellular energy regulation. Its pipeline spans neurological, muscular atrophy, metabolic, and rare disease indications, applying novel mitochondrial modulation approaches to

emerging 15.0 / 100 0 APIs View provider profile →
CompanyLife SciencesBiotechnologyPharmaceuticalsTherapeuticsMitochondrial Medicine

Pretzel Therapeutics is an API provider whose private shares are listed on 2 secondary markets: EquityZen, Nasdaq Private Market.

Where It Trades

EZ EquityZen View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.